Call for information on use of organophosphates and carbamates (OPCs)
We conducted a call for information to inform a potential reassessment of substances containing organophosphates and carbamates (OPCs) used as active ingredients in a veterinary medicine or as a pesticide.
The call for information closed at 5.00 pm on Friday 28 May 2021. A total 18 responses were received. We are currently reviewing these responses.
The focus of this call for information was substances containing the following as the active ingredient:
Five of these active ingredients (carbaryl, fenitrothion, fenthion, maldison/malathion, propoxur) are on the Priority Chemicals List.
In order to understand the current OPC landscape, we sought information on whether these substances are still in use in New Zealand, and if so, to what extent.
We believe a number of these OPCs are no longer being used. Where the use of an OPC-containing substance is declining, we sought information on this reduction of use, and any critical uses or benefits that illustrate the positive effects of those approvals which still remain in use.
Additionally, we wanted to know if any alternative substances can replace these declining-use OPC approvals.
The information we received will be used to make an initial plan on how these substances should be managed in the future and where in the reassessments programme any subsequent work on OPCs will fit.
If a reassessment application is lodged and publicly notified, you will have an opportunity to make a formal submission on the reassessment application and proposal.
Information requested for veterinary medicine products, insecticide products, and domestic use products:
- target pest and type of animal/crop treated including any off label uses (that is, uses not specified on the label)
- who uses the substance (for example, veterinarian, farmer, domestic user, pest control professional, home gardener)
- whether retaining this use is critical or has significant benefits that justify retaining an approval or a specific use pattern
- whether there are alternative substances or treatments which can replace this use including comparative information where appropriate
- any other general information about the use of the product
- why you no longer use, import, or manufacture a specific approval.
How we will use this information
The information you provided in this call for information will be used to assess the need to conduct a further reassessment and consider options for its scope. Should a formal reassessment application be made, interested parties will have an opportunity to make formal submissions on the application once it has been formally lodged.
Feedback may be made publicly available
As a regulator, we wish to run an open and transparent process to the extent possible, so the EPA may publish or otherwise make available all or part of your feedback. However, we acknowledge that some information may be commercially sensitive or be otherwise regarded as confidential. Therefore, if you consider any of the information you are providing should not be made publicly available, please clearly indicate this, and give the reasons, so we can consider this before publishing any information.
The Privacy Act 2020 establishes certain principles with respect to the collection, use, and disclosure of information about individuals by various agencies, including the EPA.
Any personal information you supply when providing feedback will be used only in relation to the matters covered by this document. We may also use your contact details for the purpose of requesting your participation in customer surveys.
You have a right to access and correct any personal information held by us, by contacting the EPA.
You may request that your personal information (such as your name) be withheld from publicly available information. We will not make your personal contact details publicly available.